AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-92
Results: 1-25/92
TREATMENT OF HYPERCHOLESTEROLEMIC PATIENTS WITH AND WITHOUT CORONARY-DISEASE WITH PRAVASTATIN DECREASES THROMBUS FORMATION UNDER DYNAMIC FLOW CONDITIONS
Authors: DANGAS G AMBROSE JA SMITH DA UNGER AH FIER C SHAO JH MERAJ P FALLON JT CHESEBRO JH BADIMON JJ
Citation: G. Dangas et al., TREATMENT OF HYPERCHOLESTEROLEMIC PATIENTS WITH AND WITHOUT CORONARY-DISEASE WITH PRAVASTATIN DECREASES THROMBUS FORMATION UNDER DYNAMIC FLOW CONDITIONS, Journal of the American College of Cardiology, 31(2), 1998, pp. 194-194
LIPID-LOWERING THERAPY REDUCES BLOOD THROMBOGENICITY IN HYPERCHOLESTEROLEMIC PATIENTS - EFFECT OF SIMVASTATIN
Authors: RAUCH U BADIMON JJ VORCHHEIMER DA GUZMAN I HARRIS K HARRIS P SANDLER DA FALLON JT FUSTER V CHESEBRO JH
Citation: U. Rauch et al., LIPID-LOWERING THERAPY REDUCES BLOOD THROMBOGENICITY IN HYPERCHOLESTEROLEMIC PATIENTS - EFFECT OF SIMVASTATIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 194-194
INHIBITORY EFFECTS OF RAPAMYCIN ON INTIMAL HYPERPLASIA AFTER PTCA IN THE PORCINE CORONARY MODEL - A 3-MONTH FOLLOW-UP
Authors: BADIMON JJ PADUREAN A ROQUE M GALLO R FALLON J CHESEBRO JH FUSTER V
Citation: Jj. Badimon et al., INHIBITORY EFFECTS OF RAPAMYCIN ON INTIMAL HYPERPLASIA AFTER PTCA IN THE PORCINE CORONARY MODEL - A 3-MONTH FOLLOW-UP, Journal of the American College of Cardiology, 31(2), 1998, pp. 278-278
TIROFIBAN IN UNSTABLE CORONARY-DISEASE - REPLY
Authors: CHESEBRO JH BADIMON JJ
Citation: Jh. Chesebro et Jj. Badimon, TIROFIBAN IN UNSTABLE CORONARY-DISEASE - REPLY, The New England journal of medicine, 339(16), 1998, pp. 1165-1165
PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE IN UNSTABLE CORONARY-DISEASE/
Authors: CHESEBRO JH BADIMON JJ
Citation: Jh. Chesebro et Jj. Badimon, PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE IN UNSTABLE CORONARY-DISEASE/, The New England journal of medicine, 338(21), 1998, pp. 1539-1541
HIRUDIN REDUCES TISSUE FACTOR EXPRESSION IN NEOINTIMA AFTER BALLOON INJURY IN RABBIT FEMORAL AND PORCINE CORONARY-ARTERIES
Authors: GERTZ SD FALLON JT GALLO R TAUBMAN MB BANAI S BARRY WL GIMPLE LW NEMERSON Y THIRUVIKRAMAN S NAIDU SS CHESEBRO JH FUSTER V SAREMBOCK IJ BADIMON JJ
Citation: Sd. Gertz et al., HIRUDIN REDUCES TISSUE FACTOR EXPRESSION IN NEOINTIMA AFTER BALLOON INJURY IN RABBIT FEMORAL AND PORCINE CORONARY-ARTERIES, Circulation, 98(6), 1998, pp. 580-587
STATIN THERAPY REDUCES BLOOD THROMBOGENICITY - EVIDENCE FOR AN ANTITHROMBOTIC EFFECT INDEPENDENT OF LDL REDUCTION
Authors: VORCHHEIMER DA RAUCH U SANDLER DA FUSTER V CHESEBRO JH ARSLAN B GUZMAN IC PALENCIA S BADIMON JJ
Citation: Da. Vorchheimer et al., STATIN THERAPY REDUCES BLOOD THROMBOGENICITY - EVIDENCE FOR AN ANTITHROMBOTIC EFFECT INDEPENDENT OF LDL REDUCTION, Circulation, 98(17), 1998, pp. 2376-2376
IN-VIVO MR CHARACTERIZATION OF PLAQUES IN THE THORACIC AORTA
Authors: FAYAD ZA NAHAR T BADIMON JJ GOLDMAN M WEINBERGER J FALLON JT AGUINALDO G SHINNAR M CHESEBRO JH FUSTER V
Citation: Za. Fayad et al., IN-VIVO MR CHARACTERIZATION OF PLAQUES IN THE THORACIC AORTA, Circulation, 98(17), 1998, pp. 2706-2706
EFFECT OF TISSUE FACTOR PATHWAY INHIBITOR ON ACUTE THROMBUS FORMATIONIN A PORCINE MODEL OF PTCA - SYNERGISTIC ANTICOAGULANT EFFECT OF TFPIAND HEPARIN
Authors: ROGUE M PADUREAN A CHESEBRO JH FUSTER V JOSE BJ
Citation: M. Rogue et al., EFFECT OF TISSUE FACTOR PATHWAY INHIBITOR ON ACUTE THROMBUS FORMATIONIN A PORCINE MODEL OF PTCA - SYNERGISTIC ANTICOAGULANT EFFECT OF TFPIAND HEPARIN, Circulation, 98(17), 1998, pp. 3811-3811
DISSOLUTION OF MURAL THROMBUS BY SPECIFIC THROMBIN INHIBITION WITH R-HIRUDIN - COMPARISON WITH HEPARIN AND ASPIRIN
Authors: MEYER BJ BADIMON JJ CHESEBRO JH FALLON JT FUSTER V BADIMON L
Citation: Bj. Meyer et al., DISSOLUTION OF MURAL THROMBUS BY SPECIFIC THROMBIN INHIBITION WITH R-HIRUDIN - COMPARISON WITH HEPARIN AND ASPIRIN, Circulation, 97(7), 1998, pp. 681-685
PROLONGED THROMBIN INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY IN PORCINE CORONARY-ARTERIES
Authors: GALLO R PADUREAN A TOSCHI V BICHLER J FALLON JT CHESEBRO JH FUSTER V BADIMON JJ
Citation: R. Gallo et al., PROLONGED THROMBIN INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY IN PORCINE CORONARY-ARTERIES, Circulation, 97(6), 1998, pp. 581-588
TISSUE PROTHROMBIN - UNIVERSAL DISTRIBUTION IN SMOOTH-MUSCLE
Authors: MCBANE RD MILLER RS HASSINGER NL CHESEBRO JH NEMERSON Y OWEN WG
Citation: Rd. Mcbane et al., TISSUE PROTHROMBIN - UNIVERSAL DISTRIBUTION IN SMOOTH-MUSCLE, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2430-2436
GUIDELINES FOR MANAGEMENT OF LEFT-SIDED PROSTHETIC VALVE THROMBOSIS -A ROLE FOR THROMBOLYTIC THERAPY
Authors: LENGYEL M FUSTER V KELTAI M ROUDAUT R SCHULTE HD SEWARD JB CHESEBRO JH TURPIE AGG
Citation: M. Lengyel et al., GUIDELINES FOR MANAGEMENT OF LEFT-SIDED PROSTHETIC VALVE THROMBOSIS -A ROLE FOR THROMBOLYTIC THERAPY, Journal of the American College of Cardiology, 30(6), 1997, pp. 1521-1526
THRESHOLD INHIBITION OF THROMBUS FORMATION BY PEG-HIRUDIN, A LONGER ACTING THROMBIN INHIBITOR
Authors: BADIMON JJ ALZUETA AF RATAN A RUBSAMEN K BADIMON L FUSTER V CHESEBRO JH
Citation: Jj. Badimon et al., THRESHOLD INHIBITION OF THROMBUS FORMATION BY PEG-HIRUDIN, A LONGER ACTING THROMBIN INHIBITOR, Thrombosis and haemostasis, 1997, pp. 364-364
ANTITHROMBOTIC EFFECTS OF PEG-HIRUDIN, A NEW AND LONG-LASTING THROMBIN INHIBITOR, IN HUMANS
Authors: KYRLE PA CHESEBRO JH FUSTER V RUBSAMEN K BADIMON JJ
Citation: Pa. Kyrle et al., ANTITHROMBOTIC EFFECTS OF PEG-HIRUDIN, A NEW AND LONG-LASTING THROMBIN INHIBITOR, IN HUMANS, Thrombosis and haemostasis, 1997, pp. 2006-2006
DEEP ARTERIAL INJURY IS ASSOCIATED WITH ACUTE AND PROLONGED THROMBIN GENERATION
Authors: GALLO R BICHLER J CHESEBRO JH FUSTER V BADIMON JJ
Citation: R. Gallo et al., DEEP ARTERIAL INJURY IS ASSOCIATED WITH ACUTE AND PROLONGED THROMBIN GENERATION, Thrombosis and haemostasis, 1997, pp. 2315-2315
PATHOGENESIS OF THROMBOSIS IN CORONARY-ARTERY DISEASE
Authors: CHESEBRO JH RAUCH U FUSTER V BADIMON JJ
Citation: Jh. Chesebro et al., PATHOGENESIS OF THROMBOSIS IN CORONARY-ARTERY DISEASE, Haemostasis, 27, 1997, pp. 12-18
RANDOMIZED DOUBLE-BLIND TRIAL OF FIXED LOW-DOSE WARFARIN WITH ASPIRINAFTER MYOCARDIAL-INFARCTION
Authors: FUSTER V CALIFF RM CHESEBRO JH COHEN M COMP PC GHEORGHIADE M HALL J HALPERIN J KHAN S KOPECKY S LANGER A MOLK B MOSS A OCONNOR CM OGARA PT RASKOB E SUTTON J BRAUNWALD E BELL WR FURBERG C RAPAPORT E DEMETS D GOLDSTEIN S RICHARDSON D HILLIS D BONOW R KISTLER JP MOHR JP SHERMAN D FISHER M FEYZI J COOK T CALIFF RM HARRINGTON RA BERKOWITZ SD JETT L BERDAN L MCDOUGAL M FRIEDMAN E DANIEL J RONCSKEVITZ E HWANG S CROWELL D PAGANINI M ANDAHL L OCONNOR C LUCAS K COLLINS GJ MARK RJ SIEGEL RM KOEHNEMANN G GREER S SCHWEITZER AC LAWRENCE JE ALLEN SM WISEMAN AH WARWICK DJ BENNETT WT SIMMONS K SHEIKH KH HENGERER T CAMPBELL PT PATTERSON JT BATES M MATHEWS A ROARK SF MARQUIS N GOLDNER DB BROWN G PARKER JP WELLS CB MCGREW FA HAMILTON B CARNEY RJ CRISPIN S CUMMINS FE NONNWEILER JM COLLINS GV HATHAWAY J CONN E MCWILLIAMS C GEROGE JM RONCEVICH T REEVES BR DINSMORE N BENDER R DEROSA K OCONNOR CM HOFFMAN S WERTHEIMER J TURNER S CRANDALL CW HIGGINS DL BERGER BC PALAZZO D FONTANET H FORD E CHU AA PIERSON M SEAWORTH JF JENSEN J HOCHE JP FORD EA GOODFIELD P SPROWLS H SCHMIDT PJ NESS C ODONNELL G MCNAMEE S KOREN MJ BAKER J HASSEL CD HARTLEY D UNKS M RODGERS K MUHLESTEIN JB ALLEN A SACCHI TJ MAJOR A KMONICEK JM SHANE JW GOULAH RD HARNER R BANNON PJ HEYL AE WALL TC MILKS S RAMO BW HEIMGARTNER K VRANIAN RB LOUDER DR STACK RK JACKSON LL BERMAN EJ HAWKINS D AYCOCK GR WILCOX T WEST SR FOWLER P ALAGONA P MOORE A HINES J MINOR JR KEREIAKES DJ MARTIN LH FRID DJ HOMAN JA BURKS JM KIRBY JC PUMA J JONES L SCHNEIDER RM LYTTLE B TALLEY JD ASHCRAFT S JOSEPH A CORUMHARTLY J MCNEER JF LADEN DL BELKIN RN WILLIAMSON J LANGER A HILL C BUTTOO K KACHRA A LANGER G KAVANNAUGH L SHRIVES DM STRAUSS H ANDERSON P KWOK K KERN C CHEUNG MT NAWROCKI H DARCEL IC ALI N CAMPBELL D SLUZAR V HINK H LAM J MARQUIS J PARKER JD WILSON J JAMES R NOLF B ZAWADOWSKI A BHARGAVA R GUPTA M SEVITT B FITZSIMONS J BURKE BR CHOMYC R SINGH N BOZEK B ROTH SL SMITH J FELL DA WILLOUGHY L RANGANATHAN N NAWROCKI H LANGER A HILL C MORGAN C BALLEZA L SASSON Z NOLF B LENKEIKERWIN S WILSON J MCALISTER NH KARHRA N GANGBAR E WILLOUGHBY L HESS A GAUDET M BHESANIA T BURGE D OGARA P HAGGAN C GIBSON M SLATER A STONE PH CLEMENTE C POLANSKY BJ CLEMENTS PJ SCHAEL F MCGOUGH E DAUM RM CAREY G GILLAM LD HALL DJ VENDITTI FJ WOODHEAD G BIRKHEAD RG MCCONNELL D JANG IK HAGGAN C SADANIANTZ A STAPLES E WEINSHEL AJ WEINSHEL G COHEN M SHERWOOD J PALABRICA T BROWN AM HACK TC PAVAO F MCKENDALL FR WHEELER JL GAUGHAN C MEDICI SE LOSORDO DW HALLETTE N WALDMAN H CRIASIA M BATTLE R ROWEN M KLEIN ME HANKIN B RADFORD MJ KEARNEY L BECKER RC BALL SP SHARMA GVRK LAPSLEY DP WATROUS BG STANTON A KOPECKY S HOLLAND A SHELHAMER L GUDMONSON K BASU HN BRICKMAN D RAMEE SR LANDRY KJ HELTNE CE BERGAL LA LYONS RM BUSSEY HI ASINGER R FIFIELD JH BRUNS DL GADIENT L KINCAID D BERG S STORVICK E WESTPHAL D REZKALLA SH WHITE E SAFFORD RE DOUCETTE K COOKMAN JJ FANGMAN L ANDERSON BJ SWAN M KOUBA C THEIGE T VACEK JL NOLTE B HURLEY DV KASKIE K GARD JR HARRE SJ SOLBERG L MILLER K MILLER RR RICKARDS J YAWN RA KURLAND M HAUGLAND JM SLIVKEN R HESSION WT STRUM S STOWERS SA ABUAN T DEWOOD MA REINHARDT S KOPECKY SL RICHARDSON D ISELE R BLOCK C SWENSON LJ VITTUM KA WEEKS G BRENNAN M CHAPMAN D THOMMORGAN J CHELLIAH N CARTER D FRIEDMAN B HAFFEY K WEBEL R ROOD M ANDREWS TC JULY ME EDIN AE HESTER TS SUTTON J MCCOLLOUGH T SCHULMAN D DELOPLAINE K BESLEY D DUNN S RICHARDS F SHIPMAN D JOSEPHSON RA JASSO D FLEISCHER L LOFRANO S SPRIGGS D WAHL S FONT VE TROTTIER M SUTTON J DELUCA SA SCHWARZ EF BECKHAM T MICKOLICH JR SNYDER M LANGHOLZ D JOHNSON E BEAVER BB TEDRICK R BOYD JJ PROBST P BEAR PA CRAIG MB BLUMENTHAL RS CARNES T VILLA AE ATKINS F STORER WQ PAYNE MA ODONNELL MJ PROCHNOW L YAKUBOV S NOETHEN A GONZALEZ M JOPPERI E JOYCE D MISHAK S REEN BM WHISNANT DR GACIOCH GM CHIODO V EFFRON MB UTLEY K FRANK S DANKOSKI C KRAUTHAMER D WELCOM GT AGUIRRE FV STONNER T CANNON L HARRIS M BROWN DL MOEHUFFORD K HATTEMER CR HOWARD W GILMORE PS WOFFORD R BATES ER ALEXANDRIS C MCCLURE JM DINNINGER J MOLK B DANHOUR G PACHECO JP LONGO JA MOLK BL BICKETT K BAUM RS JENKINS R BROCKINGTON L HARDING C LUCKASEN GJ RAYDER K PTASNIK MJ HARDING C BRACHFELD CA VINCZE T CADIGAN RA WUBBENA BA SMITH BR ONEILL D PACHELO GM GODFREY CC FECIK C LARSON D RAYDER K BACKUP LD DRAKE Z MIKLIN JS ARIS G SCHWARTZ DJ STARK S SMITH S EASTBURN T MARSH R LORENZ S THOMPSON R KLEINMAN J ARIS G BRECKINRIDGE JC DAUBER IM BELL W VANBENTHUYSEN K PREVEDEL J FECIK C STRINGER KA WHITEROCK A LEVITT PW PETRAS J COHEN M STOAKES K DANIELS S STERNBERG C MAZUZ M FRYMOYER BS DICKSTEIN RA BANGER D KRAMER JH EVANS C VICTOR M LUHMANN S WORLEY WJ TUZI J JANZER SF LYSGAARD JK STILLABOWER ME DISABATINO A VOYCE S KEATING D COHEN M STOAKES K ZAKRZEWSKI M HAYES C OWENS JS AMBURG C ZATUCHNI J BOYLE M GHEORGHIADE M MISTOVICH M ZAYAC J DEGIROLAMI D PETERSON D GLICK G REDA A HUETER D WESZT S WYNNE J LADD DF MATHEW J DAVIDSON S BORZAK S CRUZ TA CHIU C SEDLARZ P SHANES JG CALKINS M ALEXANDER J
Citation: V. Fuster et al., RANDOMIZED DOUBLE-BLIND TRIAL OF FIXED LOW-DOSE WARFARIN WITH ASPIRINAFTER MYOCARDIAL-INFARCTION, Lancet, 350(9075), 1997, pp. 389-396
TREATMENT OF ARTERIAL THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARINS
Authors: CHESEBRO JH
Citation: Jh. Chesebro, TREATMENT OF ARTERIAL THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARINS, Seminars in hematology, 34(4), 1997, pp. 26-34
VARIABILITY IN ANTICOAGULATION CONTROL PREDICTS THROMBOEMBOLISM AFTERMECHANICAL CARDIAC-VALVE REPLACEMENT - A 23-YEAR POPULATION-BASED STUDY
Authors: HUBER KC GERSH BJ BAILEY KR SCHAFF HV HODGE DO CHA RH CHESEBRO JH
Citation: Kc. Huber et al., VARIABILITY IN ANTICOAGULATION CONTROL PREDICTS THROMBOEMBOLISM AFTERMECHANICAL CARDIAC-VALVE REPLACEMENT - A 23-YEAR POPULATION-BASED STUDY, Mayo Clinic proceedings, 72(12), 1997, pp. 1103-1110
DIRECTIONS FOR IMPROVEMENT OF SUBSTITUTE HEART-VALVES - NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE WORKING GROUP-REPORT ON HEART-VALVES
Authors: EDMUNDS LH MCKINLAY S ANDERSON JM CALLAHAN TH CHESEBRO JH GEISER EA MAKANANI DM MCINTIRE LV MEEKER WQ NAUGHTON GK PANZA JA SCHOEN FJ DIDISHEIM P
Citation: Lh. Edmunds et al., DIRECTIONS FOR IMPROVEMENT OF SUBSTITUTE HEART-VALVES - NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE WORKING GROUP-REPORT ON HEART-VALVES, Journal of biomedical materials research, 38(3), 1997, pp. 263-266
THROMBOSIS TRIGGERED BY SEVERE ARTERIAL LESIONS IS INHIBITED BY ORAL-ADMINISTRATION OF A GLYCOPROTEIN IIB IIIA ANTAGONIST/
Authors: BADIMON JJ MEYER B FEIGEN LP BARON DA CHESEBRO JH FUSTER V BADIMON L
Citation: Jj. Badimon et al., THROMBOSIS TRIGGERED BY SEVERE ARTERIAL LESIONS IS INHIBITED BY ORAL-ADMINISTRATION OF A GLYCOPROTEIN IIB IIIA ANTAGONIST/, European journal of clinical investigation, 27(7), 1997, pp. 568-574
ANTITHROMBOTIC EFFECT OF PEG-HIRUDIN COMPARED TO HEPARIN AND HEPARIN PLUS C7E3
Authors: KYRLE PA CHESEBRO JH HAYES RM RUBSAMEN K FUSTER V BADIMON JJ
Citation: Pa. Kyrle et al., ANTITHROMBOTIC EFFECT OF PEG-HIRUDIN COMPARED TO HEPARIN AND HEPARIN PLUS C7E3, Circulation, 96(8), 1997, pp. 217-217
DIRECT THROMBIN INHIBITION SUPERIOR TO HEPARIN DURING AND AFTER THROMBOLYSIS - DOSE, DURATION, AND DRUG
Authors: CHESEBRO JH
Citation: Jh. Chesebro, DIRECT THROMBIN INHIBITION SUPERIOR TO HEPARIN DURING AND AFTER THROMBOLYSIS - DOSE, DURATION, AND DRUG, Circulation, 96(7), 1997, pp. 2118-2120
TISSUE FACTOR MODULATES THE THROMBOGENICITY OF HUMAN ATHEROSCLEROTIC PLAQUES
Authors: TOSCHI V GALLO R LETTINO M FALLON JT GERTZ SD FERNANDEZORTIZ A CHESEBRO JH BADIMON L NEMERSON Y FUSTER V BADIMON JJ
Citation: V. Toschi et al., TISSUE FACTOR MODULATES THE THROMBOGENICITY OF HUMAN ATHEROSCLEROTIC PLAQUES, Circulation, 95(3), 1997, pp. 594-599
Risultati: 1-25 | 26-50 | 51-75 | 76-92